BioBoston supports CMC strategy and execution from preclinical through clinical stages so your development stays aligned to regulatory expectations, manufacturing readiness, and quality requirements across global markets.
Experienced CMC regulatory and manufacturing experts
Clear strategy across drug substance and drug product
Aligned to FDA, EMA, and global expectations
Practical support that reduces rework and delays
Our Regulatory CMC support can include:
CMC is one of the most common sources of delays because evidence, documentation, and strategy often evolve at different speeds.
We help you connect development, manufacturing, and quality into a coherent story so regulators can assess your package efficiently and your team can execute without constant rework.
We define the CMC roadmap and align the work across teams and vendors.
We build or refine the submission content and support responses through review and next steps.
We confirm your product stage, manufacturing approach, timeline, and current gaps.
Yes. We support both and align the package so it is consistent and defensible.
Yes. We support question strategy, briefing content, and response preparation.
Yes. We support lifecycle CMC work, including manufacturing changes and documentation updates.